🔔 After the Bell
🎯 Session Review
Thursday turned out to be a solid day for the bulls. The S&P 500 added 0.81% to close at 7,543.64, the Nasdaq surged 1.30% to 26,206.89, and even the Dow tagged along with a modest 0.27% gain. Not every corner of the market celebrated, but the overall vibe was constructive.The labor market helped set a calm tone early. Weekly jobless claims came in at 215,000 for the week ended July 4, slightly lower than the prior week's revised 217,000. That kind of steady, not-too-hot jobs data is exactly what investors like to see. It signals the economy is holding up without giving the Fed a reason to get aggressive again.
Treasury yields dipped modestly across the curve, with the 10-year falling to 4.54% and the 5-year sliding to 4.27%. Lower yields gave growth stocks room to breathe, and the Nasdaq was happy to take full advantage.
📊 Today's Market Movers
|
▲ Gainers
|
▼ Losers
|
Your Phone Is Smarter Than Your Inbox
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🚀 Key Catalysts
Micron Technology (MU) was a standout story today. The company announced plans to invest up to 3 billion dollars to strengthen the U.S. semiconductor supply chain, a move that fits neatly into the broader domestic chip manufacturing push. That kind of capital commitment signals confidence in long-term demand and gave the semiconductor sector a meaningful lift.On the other end of the spectrum, AstraZeneca (AZN) got hit hard. Shares dropped as much as 9% after a late-stage trial of heart drug Wainua, developed in partnership with Ionis Pharmaceuticals (IONS), failed to meet its primary endpoint of reducing cardiovascular deaths and recurring heart problems. Ionis shares took an even more brutal beating, with IONS sliding over 20 points in today's session.
PepsiCo (PEP) also disappointed investors, missing earnings estimates as North American consumers continued to pull back on spending. Revenue did manage to beat expectations thanks to strong international demand, but the stock still dropped, reflecting concern that domestic consumer pressure is not going away anytime soon.
Sponsored Content
Get a piece of OpenAI pre-IPO
There's a single ticker that gives you a stake in both OpenAI and Anthropic… You don't have to wait for these revolutionary AI companies to go public. You can get in today, from any regular brokerage account, for less than $100. We'll give you the ticker symbol, completely free. No subscription required.
🎭 Investor Mood
Investor Pulse: Selectively Bullish
The mood today was best described as selective optimism. Investors were happy to chase technology and semiconductors higher while quietly stepping away from pharma and consumer staples. It is the kind of rotation that tells you people are not exactly fearful, but they are being choosy.The AstraZeneca miss rattled confidence beyond just that one stock. When a late-stage trial from a major pharma name fails this publicly, it raises uncomfortable questions about pipeline risk across the sector. Ionis taking a 24% hit in a single session is a reminder of how quickly biotech sentiment can flip.
Bitcoin ticking up 1.46% to 63,164 dollars added a small layer of risk-on energy to the day. When crypto moves in the same direction as the Nasdaq, it usually means investors are feeling comfortable enough to lean into higher-beta assets. Today had that feel.
🔍 5 Focus Points for Tomorrow
| 📈 | AZN and IONS analyst downgrades likely following the Wainua trial failure |
| 📋 | PEP earnings fallout and what North American consumer weakness means for peers |
| 🤖 | Semiconductor sector momentum following Micron's 3 billion dollar investment pledge |
| 🏛️ | Treasury yield direction as the 10-year tests support near 4.54% |
| 🌍 | PFAS litigation developments as New York's lawsuit against 3M and DuPont moves forward |
Sponsored Content
The way you've been building your wealth is working against you
In 2022, the last time the Fed made a major shift, the 60/40 portfolio had one of its worst years on record.
Bonds collapsed, stocks fell… there was nowhere to hide.
Larry Benedict saw it coming. He went 11-for-11 while most investors had no idea what hit them.
He says the same pattern is setting up now — on a much bigger scale.
💸 Bottom Line
New York's lawsuit against 3M and DuPont (DD) over forever chemicals is worth watching closely. Accusing companies of knowingly selling toxic PFAS compounds as a public nuisance is a serious legal escalation, and it opens the door for more state-level actions. DuPont shareholders have dealt with PFAS liability headlines before, and this one has the potential to drag on for years.Over in Europe, SAP avoided an EU antitrust fine by agreeing to make it easier for customers to switch providers or exit contracts. That is a meaningful concession from the continent's largest software maker, and it sets a precedent that other enterprise software companies operating in Europe should pay attention to.
Heading into Friday, keep an eye on how AstraZeneca and Ionis trade as analysts update their models and price targets following the Wainua trial failure. Also worth watching is whether Micron's supply chain commitment sparks any follow-on announcements from competitors. The semiconductor narrative has plenty of room to run.
📰 Further Reading
Elon Musk Calling on Military 'Dark Energy' to Power AI (Ad)
When it was put inside U.S. tanks, they moved almost silently and produced no smoke. Now, Elon Musk is using this strange technology to jump ahead in the AI race - and possibly change the course of history. Click here to see how this could ignite a $10 trillion boom for the stocks involved.
Click here to see how this could ignite a $10 trillion boom for the stocks involved.
BUY ALERT: America's Economist Buys 10,000 Shares of $5 Stock (Ad)
The Ex-CIA economist is convinced the Trump administration is about to invest in this company.
See why he's loading up on shares here.
Trump redacted 750 files while smelling Biden? (Ad)
Biden's smell hadn't even left the Oval Office yet… And Trump got to work immediately on the most secretive government operation since the Manhattan Project. While the world was distracted by tariffs, Trump redacted over 750 government files. Because Trump saw the writing on the wall: These files we...
Click here to see what's inside the "Redacted Trump Files" before the world finds out the shocking truth.